接受免疫抑制剂治疗的风湿病患者中乙型肝炎病毒的再激活。 - Suppr

Reactivation of hepatitis B virus in rheumatologic patients receiving immunosuppressive agents.

作者信息

Tsai Feng-Chiao, Hsieh Song-Chou, Chen Ding-Shinn, Sheu Jin-Chuan, Chen Chien-Hung

机构信息

Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, 7 Chung-Shan South Road, Taipei, Taiwan.

出版信息

Dig Dis Sci. 2006 Sep;51(9):1627-32. doi: 10.1007/s10620-006-9074-8. Epub 2006 Aug 22.

DOI:10.1007/s10620-006-9074-8

PMID:16927141

Abstract

摘要

相似文献

Reactivation of hepatitis B virus in rheumatologic patients receiving immunosuppressive agents.

Dig Dis Sci. 2006 Sep;51(9):1627-32. doi: 10.1007/s10620-006-9074-8. Epub 2006 Aug 22.

Use of tumor necrosis factor-alpha-blocking agents in hepatitis B virus-positive patients: reports of 3 cases and review of the literature.

J Rheumatol. 2009 Jun;36(6):1188-94. doi: 10.3899/jrheum.081246. Epub 2009 May 15.

Lamivudine for chemotherapy-induced reactivation of HBV: prophylaxis or treatment?

Am J Gastroenterol. 2002 May;97(5):1268-9. doi: 10.1111/j.1572-0241.2002.05722.x.

Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.

Biol Blood Marrow Transplant. 2010 Jun;16(6):809-17. doi: 10.1016/j.bbmt.2009.12.533. Epub 2010 Jan 7.

Lamivudine therapy in renal allograft recipients with hepatitis B virus infection.

Transplant Proc. 2003 Feb;35(1):278-9. doi: 10.1016/s0041-1345(02)03850-2.

Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs.

Int J Rheum Dis. 2013 Oct;16(5):527-31. doi: 10.1111/1756-185X.12154.

Combined lamivudine and interferon-alpha therapy for chemotherapy-induced reactivation of hepatitis B virus.

Am J Gastroenterol. 2003 May;98(5):1215-6; author reply 1217. doi: 10.1111/j.1572-0241.2003.07433.x.

American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.

Gastroenterology. 2015 Jan;148(1):215-9; quiz e16-7. doi: 10.1053/j.gastro.2014.10.039. Epub 2014 Oct 31.

[Nucleos(t)ides as prophylaxis for the reactivation of hepatitis B virus in immunosuppressed patients].

Zhonghua Gan Zang Bing Za Zhi. 2009 Jun;17(6):429-33.

The effect of prophylactic lamivudine on hepatitis B virus reactivation in HBsAg-positive patients with diffuse large B-cell lymphoma undergoing prolonged rituximab therapy.

Med Oncol. 2012 Jun;29(2):1237-41. doi: 10.1007/s12032-011-9974-0. Epub 2011 May 10.

引用本文的文献

Commensurate incidence and outcomes of liver enzyme elevation between anti-tumor necrosis factor users with or without prior hepatitis B virus infections.

PLoS One. 2018 Apr 25;13(4):e0196210. doi: 10.1371/journal.pone.0196210. eCollection 2018.

Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C.

World J Gastroenterol. 2017 Jun 28;23(24):4317-4323. doi: 10.3748/wjg.v23.i24.4317.

Chronic hepatitis B in children with or without malignancies: a 13-year follow-up.

World J Gastroenterol. 2015 Feb 21;21(7):2073-9. doi: 10.3748/wjg.v21.i7.2073.

Outcome in a patient with systemic lupus erythematosus and concurrent chronic hepatitis B infection.

BMJ Case Rep. 2010;2010. doi: 10.1136/bcr.09.2009.2273. Epub 2010 Mar 26.

Seroprevalence of hepatitis B and C among oncology patients in Turkey.

J Health Popul Nutr. 2011 Dec;29(6):652-5. doi: 10.3329/jhpn.v29i6.9903.

Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression.

Clin Gastroenterol Hepatol. 2009 Oct;7(10):1130-7. doi: 10.1016/j.cgh.2009.06.027. Epub 2009 Jul 1.

Reactivation of hepatitis B: pathogenesis and clinical implications.

Curr Infect Dis Rep. 2009 Mar;11(2):113-9. doi: 10.1007/s11908-009-0017-3.

Prophylactic use of lamivudine with chronic immunosuppressive therapy for rheumatologic disorders.

Rheumatol Int. 2009 May;29(7):777-80. doi: 10.1007/s00296-008-0790-6. Epub 2008 Nov 27.

本文引用的文献

Solid-organ transplantation in HBsAg-negative patients with antibodies to HBV core antigen: low risk of HBV reactivation.

Transplantation. 2005 Jun 15;79(11):1631-3. doi: 10.1097/01.tp.0000163468.80223.74.

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update.

Liver Int. 2005 Jun;25(3):472-89. doi: 10.1111/j.1478-3231.2005.01134.x.

Doxorubicin activates hepatitis B virus (HBV) replication in HBV-harboring hepatoblastoma cells. A possible novel mechanism of HBV reactivation in HBV carriers receiving systemic chemotherapy.

Anticancer Res. 2004 Sep-Oct;24(5A):3035-40.

Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy.

Br J Cancer. 2004 Apr 5;90(7):1306-11. doi: 10.1038/sj.bjc.6601699.

Chronic hepatitis B: update of recommendations.

Hepatology. 2004 Mar;39(3):857-61. doi: 10.1002/hep.20110.

Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy.

J Clin Oncol. 2004 Mar 1;22(5):927-34. doi: 10.1200/JCO.2004.05.161.

High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy.

J Viral Hepat. 2004 Jan;11(1):55-9. doi: 10.1046/j.1352-0504.2003.00467.x.

Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy.

Gastroenterology. 2003 Dec;125(6):1742-9. doi: 10.1053/j.gastro.2003.09.026.

Retrospective evaluation of the risk of hepatitis B virus reactivation after transplantation.

Transpl Infect Dis. 2003 Sep;5(3):126-31. doi: 10.1034/j.1399-3062.2003.00021.x.

Rheumatologic manifestations of hepatic diseases.

Hepatobiliary Pancreat Dis Int. 2003 Feb;2(1):32-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Reactivation of hepatitis B virus in rheumatologic patients receiving immunosuppressive agents.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献